Sponsor:
Mirati Therapeutics Inc.
Code:
NCT05853575
Conditions
Advanced Cancer
Metastatic Cancer
Malignant Neoplasm of Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Adagrasib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-10. This information was provided to ClinicalTrials.gov by Mirati Therapeutics Inc. on 2025-08-21.